Claims for Patent: 7,741,374

Summary for Patent: 7,741,374

Title:	Methods of use of fenofibric acid
Abstract:	Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.
Inventor(s):	Arnold; Kristin Anne (Morrisville, PA), Feng; Hengsheng (Cherry Hill, NJ)
Assignee:	Mutual Pharmaceutical Company, Inc. (Philadelphia, PA)
Application Number:	12/556,644
Patent Claims:	1. A method of treating a patient in need of treatment for an indication involving increased cholesterol and/or lipid levels, comprising administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer. 2. A method of treating a patient in need of treatment for mixed dyslipidemia, comprising administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer.